WILMINGTON, N.C., March 9, 2010 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Rick Randall, Chief Executive Officer, is scheduled to present at the Cowen and Company 30th Annual Health Care Conference in Boston, MA on Thursday, March 11, 2010 at 10:20 a.m. ET. Mr. Randall will provide an overview of the Company and an update on its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine.
The presentation will be webcast live and may be accessed by visiting TranS1's website at http://www.trans1.com. A replay of the webcast will also be available immediately after the conclusion of the presentation. Investors can access the webcast under the investor relations section of TranS1's website.
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. TranS1 currently markets the AxiaLIF family of products for single and multilevel lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.
CONTACT: TranS1 Inc.
Investors:
Rick Randall, Chief Executive Officer
910-332-1700
Westwicke Partners
Mark Klausner
443-213-0501
mark.klausner@westwicke.com
